Received Jul 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Permanent neuropathy issues many others have gotten from taking it; This serious case was reported by a consumer via interactive digital media and described the occurrence of neuropathy in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced neuropathy (Verbatim: Permanent neuropathy issues many others have gotten from taking it) (serious criteria GSK medically significant). The outcome of the neuropathy was not reported. The reporter considered the neuropathy to be related to Shingles vaccine. The company considered the neuropathy to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 04-JUL-2025 This case was reported by a patient via interactive digital media. The reporter said that probably not as bad as the permanent neuropathy issues many others have gotten from taking Shingles vaccine. This case is linked with US2025AMR085363, reported by same reporter.; Sender's Comments: A case of Neuropathy peripheral, an unknown time after receiving Shingles vaccine, in a female subject. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received. US-GSK-US2025AMR085363:Same reporter